The sales, technical and operations team working directly with veterinary practices across the UK.
Allison leads sales at Photon Therapeutics, having started her career as a veterinary nurse before spending 15+ years in veterinary pharmaceutical sales with several worldleading animal health companies, most recently at Antech (Mars). Her clinical roots keep her commercial strategy tied to real outcomes for vets, nurses and pet owners as she scales Photon Therapeutics’ international operations.
A veterinary surgeon from the University of Bristol, Helen spent five years in small animal practice before moving into industry with Dechra, TVM/Domes Pharma and Boehringer Ingelheim, where she led a 10-strong technical services team. At Photon Therapeutics she supports education around PhotonUVC Vet, drawing on a strong interest in antimicrobial stewardship.
Becky brings more than two decades of pharmaceutical sales experience and a background in microbiology to her role supporting veterinary practices across the North of England, Scotland and Northern Ireland. 12 years in veterinary pharmaceutical sales with Merial and Boehringer Ingelheim have helped her build long-standing relationships within the sector.
Lucinda holds a master’s degree in Equine Science and built her career across equine and veterinary pharmaceutical sales before joining Photon Therapeutics to cover the South-West and West Midlands. She’s focused on building relationships with veterinary teams as Photon Therapeutics’ technology moves into everyday practice.
Anouska’s career spans clinical practice as a veterinary nurse, sales at Agria Pet Insurance, Hill’s Pet Nutrition and Dechra, plus senior sales leadership roles including UK Sales Manager and Sales Director at PLH Medical. She joins Photon Therapeutics to guide veterinary practices through onboarding and provide ongoing support, working closely with vets and their teams to make PhotonUVC Vet part of everyday care.
Sarah is Executive Assistant to CEO Mark Leddy at Photon Therapeutics. Her background spans the RAF, private aviation, waste management and veterinary healthcare, including General Manager of a large veterinary referral centre and running her own virtual assistant business. Her knowledge of first-opinion and referral practice shows her how the PhotonUVC Vet fits clinical workflows and buying decisions.
Founders & Board Members.
Co-founders and board members supporting Photon Therapeutics.
Dr. Simon Dean
CO-FOUNDER
Dr Simon Dean is an ophthalmologist based in New Zealand with a keen interest in optoelectronics. In 2007 he was awarded fellowship of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO). He completed fellowship training in the UK in oculoplastics and ocular oncology in Glasgow, followed by cataracts and anterior segment in Birmingham, UK, and the Bedford branch of Moorfields Eye Hospital. He is inventor of the Photon Therapeutics device, having built the first prototypes and coordinated the research to support this novel technology.
Prof. Sunil Shah
CO-FOUNDER
Professor Sunil Shah qualified from St. Georges Hospital Medical School and has been a Consultant at the Birmingham and Midland Eye Centre since 2000, where he runs a cornea and cataract service. He is a Professor at Aston University, provides specialist advice to NICE, and is a past President of the British Society for Refractive Surgery and the British Contact Lens Association. In 2014 and 2018 he was voted among the top 100 most influential people in Ophthalmology worldwide, and in 2020 won the ASCRS Winning Pitch for the Photon Therapeutics invention
Dr. Mark Leddy
TERRITORY BUSINESS MANAGER
Mark Leddy is a highly accomplished senior leader with a proven track record in both B2B and B2C sectors, particularly within animal health and healthcare service operations. He thrives in rapidly growing businesses and has demonstrated expertise across strategy, change management, sales, marketing, business development and regulatory compliance. His academic credentials include an MBA with Distinction from Warwick Business School and a BVSc with Distinction as a Veterinary Surgeon.
Ben Wanders
NON-EXECUTIVE DIRECTOR
Ben is a serial entrepreneur, founder and board-level advisor with over four decades of experience in scaling ophthalmic medical device companies through growth and exit phases. He has led companies through international expansion and M&A. Ben holds 12 patents in ophthalmic lens technology. He has been a shareholder in Photon Therapeutics since 2021 and is now a Non-Executive Director who will be supporting strategy and long-term thinking.
Nick Holzherr
NON-EXECUTIVE DIRECTOR
Nick is an entrepreneur, investor and the CEO of Whisk (acquired by Samsung). He founded Whisk in 2012, raised $2m from investors to scale the company, then led it to profitability, presenting Whisk to Lord Sugar in the final of the BBC Apprentice 2012. In 2017 Nick was awarded an honorary doctorate from Aston University, and has been featured in Newsweek, The Guardian, The Telegraph, the BBC and The Next Web.
Get in Touch.
Questions about the PhotonUVC, distribution or partnerships? Our team is here to help.